Arizona State Retirement System Sells 7,696 Shares of Ventas, Inc. $VTR

Arizona State Retirement System reduced its stake in Ventas, Inc. (NYSE:VTR) by 5.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 124,635 shares of the real estate investment trust’s stock after selling 7,696 shares during the period. Arizona State Retirement System’s holdings in Ventas were worth $9,644,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in VTR. UBS Group AG lifted its holdings in Ventas by 142.4% during the third quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock worth $245,514,000 after acquiring an additional 2,060,770 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Ventas by 2.5% during the third quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after acquiring an additional 1,802,515 shares in the last quarter. Lasalle Investment Management Securities LLC lifted its holdings in Ventas by 1,135.1% during the third quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after acquiring an additional 1,427,151 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Ventas by 74.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,586,405 shares of the real estate investment trust’s stock worth $181,022,000 after acquiring an additional 1,101,948 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in Ventas by 21.5% during the third quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock worth $409,274,000 after acquiring an additional 1,034,634 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors.

Ventas Stock Performance

Shares of Ventas stock opened at $83.75 on Friday. The firm has a market cap of $39.82 billion, a price-to-earnings ratio of 155.09, a price-to-earnings-growth ratio of 2.04 and a beta of 0.75. The stock’s 50-day moving average is $84.70 and its 200-day moving average is $79.58. Ventas, Inc. has a one year low of $61.76 and a one year high of $88.36. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.85 earnings per share for the current fiscal year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were given a $0.52 dividend. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Tuesday, March 31st. Ventas’s dividend payout ratio (DPR) is presently 385.19%.

Analyst Ratings Changes

Several research firms have weighed in on VTR. Cantor Fitzgerald reiterated an “overweight” rating and set a $93.00 target price on shares of Ventas in a report on Monday, February 9th. Scotiabank lifted their target price on Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Citigroup lifted their price target on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Weiss Ratings restated a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, February 9th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $90.47.

Insider Transactions at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. 0.53% of the stock is currently owned by insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.